Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

INTRODUCTION: The objective of the study was to investigate the impact of newer biologic treatments including rituximab, abatacept and tocilizumab on antibody response following pneumococcal vaccination using a 7-valent conjugate vaccine in patients with established rheumatoid arthritis (RA). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Crnkic Kapetanovic, Meliha, Saxne, Tore, Jönsson, Göran, Truedsson, Lennart, Geborek, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978887/
https://www.ncbi.nlm.nih.gov/pubmed/24286269
http://dx.doi.org/10.1186/ar4358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978887/
https://www.ncbi.nlm.nih.gov/pubmed/24286269
http://dx.doi.org/10.1186/ar4358

Ejemplares similares